Skip to content
Canadian orders above $200 ship free · Dispatched from Canadian stock

Metabolic research peptides in Canada

Metabolic research takes in compounds examined for how they act on appetite hormones, insulin release and energy use. Retatrutide and tirzepatide are incretin receptor agonists with sizeable human trial records; cagrilintide is a long-acting amylin analogue. MOTS-C, AOD-9604, 5-Amino-1MQ and SLU-PP-332 have mostly been studied in rodents and cell culture, and their pages make that clear.

How these compare

CompoundClassSizesFrom
RetatrutideGIP, GLP-1 and glucagon receptor agonist10 mg · 20 mg · 30 mg$87.00
TirzepatideGIP and GLP-1 receptor agonist20 mg · 40 mg$77.50
CagrilintideLong-acting amylin analogue (amylin receptor agonist)5 mg · 10 mg$43.00
5-Amino-1MQSmall-molecule nicotinamide N-methyltransferase (NNMT) inhibitor50 mg$62.00
AOD-9604Modified C-terminal fragment of human growth hormone5 mg$57.00
Retatrutide + CagrilintideTwo-peptide research blend (GIP, GLP-1 and glucagon receptor agonist + long-acting amylin analogue)15 mg$104.00